LL-37 Truncated Variants (KR-12 / KS-30) vs GHRP-1
Shorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity. versus First-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6.
LL-37 Truncated Variants (KR-12 / KS-30)
RecoveryShorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.
Top benefits
- ✓Antimicrobial activity preserved
- ✓Lower hemolysis vs full LL-37
- ✓Wound healing research
GHRP-1
PerformanceFirst-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6.
Top benefits
- ✓Stimulates pituitary GH release
- ✓Synergizes with GHRH analogs
- ✓Lean mass support
| Attribute | LL-37 Truncated Variants (KR-12 / KS-30) | GHRP-1 |
|---|---|---|
| Category | Recovery | Performance |
| Type | linear | linear |
| Chain length | 12 aa | 7 aa |
| Formula | KR-12 fragment of LL-37 | C46H56N12O6 |
| Common dose | Not established | 100-300 mcg |
| Frequency | N/A | 1-3x daily |
| Top benefit | Antimicrobial activity preserved | Stimulates pituitary GH release |
| Top side-effect | Localized irritation (topical) | Mild cortisol/prolactin rise |
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.